Encompass Health (NYSE:EHC) PT Raised to $100.00
Encompass Health (NYSE:EHC) had its target price raised by SunTrust Banks from $90.00 to $100.00 in a research report sent to investors on Monday, Stock Target Advisor reports. SunTrust Banks currently has a buy rating on the stock.
A number of other equities research analysts also recently commented on the company. ValuEngine downgraded Encompass Health from a buy rating to a hold rating in a research report on Wednesday, October 30th. Credit Suisse Group raised their price objective on Encompass Health from $77.00 to $89.00 and gave the stock an outperform rating in a research note on Wednesday, January 15th. BMO Capital Markets lifted their target price on Encompass Health from $85.00 to $88.00 and gave the stock an outperform rating in a report on Tuesday, January 14th. Mizuho boosted their target price on Encompass Health from $84.00 to $87.00 and gave the stock a buy rating in a research report on Monday. Finally, UBS Group upped their target price on Encompass Health from $80.00 to $87.00 and gave the company a buy rating in a report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of $83.25.
Encompass Health stock traded up $0.17 during mid-day trading on Monday, hitting $82.58. The company’s stock had a trading volume of 15,914 shares, compared to its average volume of 677,951. The company has a quick ratio of 0.97, a current ratio of 1.05 and a debt-to-equity ratio of 1.93. The stock has a market capitalization of $8.07 billion, a P/E ratio of 22.78, a P/E/G ratio of 2.43 and a beta of 0.90. Encompass Health has a twelve month low of $56.74 and a twelve month high of $83.02. The stock’s fifty day moving average price is $75.57 and its two-hundred day moving average price is $68.27.
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Further Reading: What are economic reports?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.